share_log

Subdued Growth No Barrier To Shenzhen Original Advanced Compounds Co., Ltd.'s (SHSE:603991) Price

Subdued Growth No Barrier To Shenzhen Original Advanced Compounds Co., Ltd.'s (SHSE:603991) Price

增長疲軟,對深圳原創高分子材料有限公司沒有障礙”s (SHSE: 603991) 價格
Simply Wall St ·  2023/11/10 07:40

When close to half the companies in the Chemicals industry in China have price-to-sales ratios (or "P/S") below 2.4x, you may consider Shenzhen Original Advanced Compounds Co., Ltd. (SHSE:603991) as a stock to avoid entirely with its 14.8x P/S ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.

當中國化工行業將近一半的公司的市銷比(或 “市盈率”)低於2.4倍時,你可以考慮 深圳原創高分子化合物有限公司 (SHSE: 603991) 是一隻完全值得避開的股票,市盈率爲14.8倍。儘管如此,我們需要進行更深入的挖掘,以確定市盈率大幅上漲是否有合理的基礎。

View our latest analysis for Shenzhen Original Advanced Compounds

查看我們對深圳原創先進化合物的最新分析

ps-multiple-vs-industry
SHSE:603991 Price to Sales Ratio vs Industry November 9th 2023
SHSE: 603991 市銷比與行業的對比 2023 年 11 月 9 日

How Has Shenzhen Original Advanced Compounds Performed Recently?

深圳原創先進化合物最近表現如何?

Recent times have been quite advantageous for Shenzhen Original Advanced Compounds as its revenue has been rising very briskly. The P/S ratio is probably high because investors think this strong revenue growth will be enough to outperform the broader industry in the near future. If not, then existing shareholders might be a little nervous about the viability of the share price.

最近,深圳原創先進化合物具有相當大的優勢,因爲其收入增長非常迅速。市盈率可能很高,因爲投資者認爲這種強勁的收入增長足以在不久的將來跑贏整個行業。如果不是,那麼現有股東可能會對股價的可行性感到有些緊張。

Want the full picture on earnings, revenue and cash flow for the company? Then our
想全面了解公司的收益、收入和現金流嗎?然後我們的
free
免費的
report on Shenzhen Original Advanced Compounds will help you shine a light on its historical performance.
關於深圳原裝先進化合物的報告將幫助您揭示其歷史表現。

What Are Revenue Growth Metrics Telling Us About The High P/S?

關於高市盈率,收入增長指標告訴我們什麼?

The only time you'd be truly comfortable seeing a P/S as steep as Shenzhen Original Advanced Compounds' is when the company's growth is on track to outshine the industry decidedly.

只有當公司的增長有望明顯超越行業時,你才能真正放心地看到像深圳原創高階化合物一樣高的市盈率。

If we review the last year of revenue growth, the company posted a terrific increase of 113%. However, this wasn't enough as the latest three year period has seen the company endure a nasty 44% drop in revenue in aggregate. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenues over that time.

如果我們回顧一下去年的收入增長,該公司公佈了113%的驚人增長。但是,這還不夠,因爲在最近三年中,該公司的總收入下降了44%。因此,不幸的是,我們必須承認,在此期間,該公司在增加收入方面做得並不出色。

Comparing that to the industry, which is predicted to deliver 31% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.

相比之下,該行業預計將在未來12個月內實現31%的增長,根據最近的中期收入業績,該公司的下行勢頭令人震驚。

In light of this, it's alarming that Shenzhen Original Advanced Compounds' P/S sits above the majority of other companies. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. There's a very good chance existing shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the recent negative growth rates.

有鑑於此,令人震驚的是,深圳Original Advanced Compounds的市盈率高於大多數其他公司。看來大多數投資者都忽視了最近糟糕的增長率,他們希望公司的業務前景出現轉機。如果市盈率降至與最近的負增長率更加一致的水平,現有股東很有可能爲未來的失望做好準備。

What Does Shenzhen Original Advanced Compounds' P/S Mean For Investors?

深圳原創高級化合物的市盈率對投資者意味着什麼?

It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

有人認爲,價格與銷售比率是衡量某些行業價值的次要指標,但它可能是一個有力的商業情緒指標。

We've established that Shenzhen Original Advanced Compounds currently trades on a much higher than expected P/S since its recent revenues have been in decline over the medium-term. Right now we aren't comfortable with the high P/S as this revenue performance is highly unlikely to support such positive sentiment for long. If recent medium-term revenue trends continue, it will place shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

我們已經確定,深圳Original Advanced Componds目前的市盈率遠高於預期,因爲其最近的收入在中期內一直在下降。目前,我們對高市盈率不滿意,因爲這種收入表現極不可能長期支撐這種樂觀情緒。如果最近的中期收入趨勢繼續下去,將使股東的投資面臨重大風險,潛在投資者面臨支付過高溢價的危險。

Plus, you should also learn about these 2 warning signs we've spotted with Shenzhen Original Advanced Compounds.

另外,你還應該了解這些 我們在深圳原裝先進化合物中發現了兩個警告信號

If these risks are making you reconsider your opinion on Shenzhen Original Advanced Compounds, explore our interactive list of high quality stocks to get an idea of what else is out there.

如果這些 風險讓你重新考慮你對深圳原裝先進化合物的看法,瀏覽我們的高品質股票互動清單,了解還有什麼。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎? 取得聯繫 直接和我們在一起。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。 我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。 它不構成買入或賣出任何股票的建議,也沒有考慮您的目標或財務狀況。我們的目標是爲您提供由基本面數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。簡而言之,華爾街在上述任何股票中都沒有頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論